Comparison of Effect of Morphine-Chlorpheniramine Combined Versus Morphine Alone in Alleviating Acute Renal Colic Pain: A Randomized Clinical Trail


Behrad Ziapor 1 , Hassan Motamed 1 , * , Mohammadreza Maleki Verki 1 , Hassan Norani 1

1 Emergency Medicine Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran

How to Cite: Ziapor B, Motamed H, Maleki Verki M, Norani H. Comparison of Effect of Morphine-Chlorpheniramine Combined Versus Morphine Alone in Alleviating Acute Renal Colic Pain: A Randomized Clinical Trail, Jundishapur J Nat Pharm Prod. 2017 ; 12(3):e15585. doi: 10.5812/jjnpp.15585.


Jundishapur Journal of Natural Pharmaceutical Products: 12 (3); e15585
Published Online: August 31, 2017
Article Type: Research Article
Received: June 13, 2017
Revised: July 2, 2017
Accepted: August 2, 2017


Background: Renal colic is a significant painful condition that needs urgent and influential treatment by proper analgesics. The studies showed that histamine receptors expressed in the ureter and causes strong peristaltic contractions in the ureter. The concept of this study assumed that Chlorpheniramine, propylamine H1-receptor antagonist (antihistamine), may have an effective role in management of renal colic pain.

Methods: In this randomized clinical trial, 112 patients with renal colic were divided into 2 groups, the intervention group (group A) received 1cc of intravenous chlorpheniramine along with 5 mg morphine. While group B patients received 1 cc of Isotonic solution along with 5 mg morphine. The pain was measured by visual analog scale, before the treatment and 4 time points after treatment including; 15, 30, 45, and 60 minutes after intervention.

Results: Patients’ mean age was 40.20 ± 7.21. The amount of pain score, immediately before starting intervention, time point of 15 minutes and 60 minutes after had no statistical significant differences between 2 groups, however, there were significant differences in the time point of 30 and 45 minutes. Moreover the results showed that use of Chlorpheniramine are in relation with lowering incidence of nausea,vomiting, as well as decreases the morphine required dose.

Conclusions: Our results indicated that Chlorpheniramine may be an effective agent in reliving renal colic pain. Moreover it has been shown that the use of Chlorpheniramine are in relation with lowering incidences of nausea, vomiting, as well as also decreases the morphine required dose. We conclude that additional chlorpheniramine can lower the needed dose for opioids and can probably diminish the opioids adverse effects.

1. Background

Urolithiasis is very common and is one of the common causes of emergency departments visits. The urolithiasis prevalence proportion in Iran is 5.7%, the incidence rate is 145/100,000 and its recurrence rate is 36% (1). Renal colic presents as complex symptoms characteristic for the presence of stone, which obstructs ureter. Ordinarily, the characteristic of pain is of sudden sensing in flanks and sometimes radiates to the system of genital. Moreover other symptoms include nausea, vomiting, and hematuria may be seen (2). Renal colic needs urgent and influential medication with pain killers such as narcotics, with or without spasmolytic drugs. The most frequently used agents are Pethidine and morphine (3).

The mechanism of action of opioids are through binding to specific proteins, named opioid receptors. Opioid receptors expressed in central and peripheral nervous systems. The opioid analgesic effects mediates via mu opioid receptor activation. Therefore, opioids, which are used as pain killers, are known as, “mu agonists” (4). In fact, several pathways enrolled in renal colic pain that include urinary obstruction with stone, urinary ducts` wall pressure, ureter smooth muscle spasm, stone area tissue edema and inflammation, as well as peristalsis aggravation (5, 6). The histamine-1 (H1) receptors have a wide distribution in body cells. Recently the studies showed that histamine receptors are also expressed in the ureter. Histamine can cause strong peristaltic contractions in the ureter (7).

Chlorpheniramine, propylamine H1-receptor antagonist (antihistamine), is used for allergy treatment. It is usually prescribe for flu and allergies. The half-lives of the drug elimination is varying 18 - 43 hours (8). We hypothesize that Chlorpheniramine can relieve renal colic pain by decreasing peristaltic contractions in the ureter. Therefore, the aim of this study was considered as a comparison of analgesic effect of morphine with and without Chlorpheniramine in patients with acute renal colic.

2. Methods

2.1. Study Design

In this randomized clinical trial, the patients suspected to renal colic who were admitted to the emergency departments of our university hospitals were recruited to the study. The inclusion criteria included individuals the age of 18 to 65 years, symptoms associated with acute renal colic, and the stone that was confirmed by kidney-bladder-urinary tract ultrasound or computed tomography scan. While patients under the age of 18 or above 65 years old, patients with signs related to a fever (temperature greater than 38 celsius degrees), absence of stone in radiologic evaluations, and abnormality in urinary tract were excluded from the study. Furthermore, patients with C criteria were excluded; angle-closure glaucoma, benign prostatic hypertrophy, peptic ulcer disease, bladder neck obstruction, gastric outlet obstruction, chronic obstructive pulmonary disease, asthma, urinary retention, hyperthyroidism, and cardiovascular diseases. This study was approved by Ahvaz Jundishapur University of Medical Sciences ethic committee. The study protocol was explained for all the patients. They were included after signed informed consent.

2.2. Therapeutic Intervention

The patients were randomly divided into 2 groups by block randomization method. Patients in group A received 1cc of intravenous chlorpheniramine containing 10 mg along with 5 mg of morphine sulfate. While group B patients received 1 cc Isotonic normal saline along with 5 mg morphine. Before treatment of pain, the score was measured by visual analog scale (VAS). The VAS scale, an adult unidimensional measure of pain intensity have 10 level points of representation of pain severity.

After the intervention, in time point including immediately before drug administration and 15, 30, 45, and 60 minutes after treatment the amount of pain was measured. All of the patients were followed up for 4 hours after treatment. The incidence of drug related adverse effects such as nausea, vomiting, vertigo, and constipation were evaluated. The patients whom did not response to trial analgesics after 60 minute of intervention, received another morphine rescue dose of 5 mg (Figure 1).

2.3. Statistical Analysis

The sample size was calculated 110/ group in respect of power of 90% of study, 0.05 type I error and correlation of 0.25. At first, the data obtained were examined in terms of descriptive indicators and then, to compare quantities between the 2 groups, according to normality of data, t-test and Mann-Whitney test were used. Normality of data was evaluated by Kolmogorov-Simonov normality. Statistical analysis was performed using the SPSS version 20. A P value < 0.05 assumed as significant.

3. Results

A total of 122 patients were included in the study, where 10 patients were dropped off due to the fact that they didn't meet the exclusion criteria or decline to participate in the study (Figure 1). Patients’ demographic characteristics have been shown in Table 1. Based on these results, age and sex distribution has no significant differences between the 2 groups. The mean age of patients was 40.20 ± 7.21 years. Furthermore, the participants have no impaired level of consciousness, drug allergy, and opiate addiction (Table 1).

Table 1. Patients Characteristicsa
VariablesMorphine + Chlorpheniramine (n = 56)Morphine (n = 56)P Value
Age, y41 ± 6.14.23 ± 7.20.23
Vital signs
Systolic pressure135.75 ± 20132 ± 180.56
Diastolic pressure76.23 ± 7.278.31 ± 6.30.59
Respiratory rate17.32 ± 4.2116.71 ± 3.110.47

aValues are expressed as mean ± SD or %.

The amount of pain before starting an intervention has no statistical significant differences between 2 groups. After treatment in group A, VAS score decreased from 8.5 to 2.1 and in group B it decreased from 9.1 to 2.7. Point to point analyzing showed that pain amount has no significant differences in the minutes 15 and 60 after intervention, however, statistically, there were significant differences in the pain score of time point of minutes 30 and 45 after intervention (Table 2). Moreover vital signs including blood pressure and breath rate have no differences between the groups.

Table 2. Comparison of Drug efficacy in Group A and B
VariablesTimeMorphine (n = 56)Morphine + Chlorpheniramine (n = 56)P Value
Pain scoreBefore intervention8.59.10.70
15 min after intervention6.470.33
30 min after intervention5.26.50.01
45 min after intervention3.24.10.02
60 min after intervention2.12.70.12
Nausea and vomiting, %57900.001

The most common drugs adverse effects including nausea and vomiting were evaluated and compared between the groups. The patients receiving morphine along with chlorpheniramine showed less incidence of nausea and vomiting against those receiving morphine alone (Table 2). The patients who received morphine rescue dose after minute 60 after initial intervention in trial group A were more than group B, which was statistically significant (P = 0.04).

4. Discussion

Cholelithiasis is a common disease and a prevalent etiology of emergency department referrals with a prevalence proportion of 5.7% in Iran (1). The incidence of renal colic was increased in the past decades, it may be due to changes in the general population life style (9). Urgent and influential medications consist of spasmolytic drug and opioids.

The current most frequently used agents for pain relieving of patients with renal colic are pethidine and morphine (3). Prescribing opioids make some challenges in emergency departments for their interferes with evaluating the level of consciousness, and possible need for continuous monitoring (10). Therefore, this investigation focused on the ways that limits use of such drugs. This was the reason for designation of the current trial.

Our findings indicated that the patients in group A and B showed a significantly decrease in the pain score. However, the pain score in the time points of 30 and 45 in group A was significantly less than group B. This results suggest that using Chlorpheniramine along with Morphine can be more effective that morhpine alone in managing patients with acute renal colic. After determination of histamine receptors in ureter by Bertaccini et al. it has been suggested that they can make peristalsis effect during renal colic (7). After that, use of histamine 1 receptor antagonists in management of patients with renal colic were evaluated. Yilmaz et al. in a double blind randomized study, evaluated the pain reliving efficacy of histamine 1 receptor antagonist in patients with renal colic. They divided 86 patients with urinary system stones into 2 groups; group 1 received 50 mg intramuscular (IM) dimenhydrinate and group 2 received placebo consist of only 2 cc intramuscular isotonic saline. They conclude that dimenhydrinate is effective in relieving renal colic pain, nausea, as well as vomiting (11). One of the most causes of renal colic pain is usually associated to the ureter soft muscle contraction due to the presence of stones (12). Ugaily-Thulesius et al. showed that extra histamine is related to high frequency of contractions in utterer. Furthermore, they showed that under pathological conditions such as renal colic mast cells of ureters releases histamine, which lead to contraction and consequent pain (13). In another study they showed that urothelial damage in ureteral stone can penetrate subepithelially and make degranulation of mast cells mediators that includes histamines (14).

Collectively, these results indicated that Chlorpheniramine may block histamine receptors on ureter cells and subsequently decreases the peristaltic contractions in the ureter. Moreover the results showed that use of Chlorpheniramine are in relation with lowering incidence of nausea and vomiting and also decreases the morphine needed dose. We conclude that additional chlorpheniramine can lower the needed dose for opioids and can probably diminish the opioids adverse effects.




  • 1.

    Pourmand G, Pourmand B. Urolithiasis. 2012; : 85 -7

  • 2.

    Davenport K, Waine E. The Role of Non-Steroidal Anti-Inflammatory Drugs in Renal Colic. Pharmaceuticals (Basel). 2010; 3(5) : 1304 -10 [DOI][PubMed]

  • 3.

    Edwards J, Meseguer F, Faura C, Moore RA, McQuay HJ, Derry S. Single dose dipyrone for acute renal colic pain. Cochrane Database System Rev. 2002; [DOI]

  • 4.

    Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008; 16(5) : 405 -16 [DOI][PubMed]

  • 5.

    Holdgate A, Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ. 2004; 328(7453) : 1401 [DOI][PubMed]

  • 6.

    Davenport K, Timoney AG, Keeley FX. Conventional and alternative methods for providing analgesia in renal colic. BJU Int. 2005; 95(3) : 297 -300 [DOI][PubMed]

  • 7.

    Bertaccini G, Zappia L, Bezzi E, Potenzoni D. Histamine receptors in the human ureter. Pharmacol Res Commun. 1983; 15(2) : 157 -66 [PubMed]

  • 8.

    Yasuda SU, Zannikos P, Young AE, Fried KM, Wainer IW, Woosley RL. The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine. Br J Clin Pharmacol. 2002; 53(5) : 519 -25 [PubMed]

  • 9.

    Alleemudder A, Tai XY, Goyal A, Pati J. Raised white cell count in renal colic: Is there a role for antibiotics? Urol Ann. 2014; 6(2) : 127 -9 [DOI][PubMed]

  • 10.

    Vella-Brincat J, Macleod AD. Adverse effects of opioids on the central nervous systems of palliative care patients. J Pain Palliat Care Pharmacother. 2007; 21(1) : 15 -25 [PubMed]

  • 11.

    Yilmaz E, Batislam E, Deniz T, Yuvanc E. Histamine 1 receptor antagonist in symptomatic treatment of renal colic accompanied by nausea: two birds with one stone? Urology. 2009; 73(1) : 32 -6 [DOI][PubMed]

  • 12.

    Mehdi Hosseini M. Comparison of the Therapeutic Effects of Rectal Diclofenac Sodium and Intramuscular Pethidine Injection in the Treatment of Acute Renal Colic: A Randomized Clinical Trail. J Clin Trials. 2015; 5(3)[DOI]

  • 13.

    Ugaily-Thulesius L, Thulesius O, Angelo-Khattar M, Sivanandasingham P, Sabha M. Mast cells and histamine responses of the ureter, ultrastructural features of cell-to-cell associations and functional implications. Urol Res. 1988; 16(4) : 287 -93 [PubMed]

  • 14.

    Ugaily-Thulesius L, Thulesius O. The effects of urine on mast cells and smooth muscle of the human ureter. Urol Res. 1988; 16(6) : 441 -7 [PubMed]

  • Copyright © 2017, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.